z-logo
open-access-imgOpen Access
Long-term application of lepirudin on chronic haemodialysis over 34 months after heparin-induced thrombocytopenia
Author(s) -
B Gay,
Hans-Rudolf Räz,
Hans-Rudolf Schmid,
Jürg H. Beer
Publication year - 2007
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfm032
Subject(s) - medicine , lepirudin , heparin induced thrombocytopenia , heparin , hemodialysis , surgery , platelet , argatroban , thrombin
adenine with La (Figure 3A in [1]). These results can only be due to contamination either in the animal facility or during sample analysis. Toxicology studies require meticulous attention to separation of laboratory animals and samples, far more than is necessary for other laboratory studies. As was pointed out in the correspondence of Rambeck [4], the high lung La levels that were reported by Lacour et al. may very well represent La that was inhaled from the powdered diet. Furthermore, the plasma phosphorus levels were markedly reduced by La in both models of CRF used by Lacour et al. [1] and the decreased serum phosphorus may very well have contributed to the reduction in organ weight that they found. To exclude phosphorus depletion as a cause for any apparent changes in organ weight, we introduced a control group with adenine-induced renal failure fed an adenine-low phosphorus diet for the last four weeks of the study. In summary, ingested La did not cause a reduction in liver weight in our study nor any hepatotoxicity in ours and other studies as well as in patient studies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom